Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
High EPA
DIETARY_SUPPLEMENT
2 trials
Sponsors
Laval University
, Wei Jiang
Conditions
Cardiovascular Disease, Inflammation
Depression
Phase 3
Omega 3 for Treatment of Depression in Patients With Heart Failure
Completed
NCT02057406
Wei Jiang
Depression
Start: 2014-05-31
End: 2016-12-02
Updated: 2018-05-14
Unknown Phase
Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)
Completed
NCT01810003
Laval University
Cardiovascular Disease, Inflammation
Start: 2013-03-31
End: 2017-12-31
Target: 170
Updated: 2018-02-22
Related Papers
Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study.
2020-06-15
5 citations
Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
2018-08-08
39 citations
A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
2016-06-08
175 citations